RecruitingPhase 2NCT05775042

Clinical Study of CM338 in the Treatment of Immunoglobulin A Nephropathy

Studying IgA Nephropathy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Keymed Biosciences Co.Ltd
Principal Investigator
Jicheng Lv
Peking University First Hospital
Intervention
CM338(biological)
Enrollment
70 enrolled
Eligibility
18-75 years · All sexes
Timeline
20232027

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05775042 on ClinicalTrials.gov

Other trials for IgA Nephropathy

Additional recruiting or active studies for the same condition.

See all trials for IgA Nephropathy

← Back to all trials